Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism

BACKGROUND: There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolipoprotein(a) polymorphism are associated with angiographically assessed asymptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Gazzaruso, Carmine, Garzaniti, Adriana, Giordanetti, Stefano, Falcone, Colomba, Fratino, Pietro
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149426/
https://www.ncbi.nlm.nih.gov/pubmed/12473160
http://dx.doi.org/10.1186/1475-2840-1-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149426/
https://www.ncbi.nlm.nih.gov/pubmed/12473160
http://dx.doi.org/10.1186/1475-2840-1-5

Ejemplares similares